retatrutide weight loss injection Phase III study demonstrates 30% A New Obesity Drug Delivered

Papaconstantinou, I

May 1, 2025: Lawsuits Against Makers of GLP-1 Products Like Mounjaro Exceed 1,800 There are 1,809 active cases in the federal multidistrict litigation against Eli Lilly and others who make GLP-1s like Mounjaro

Both compounds cause primarily gastrointestinal side effects that peak during dose escalation

How Retatrutide Works (Mechanism of Action) In biochemical and preclinical research models, retatrutide interacts with three class B G protein coupled receptors that participate in metabolic signaling networks: the glucagon like peptide 1 receptor (GLP 1R), the glucose dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)

Critical nodes in signalling pathways: insights into insulin action